Grace Li

New therapeutic avenue in the fight against chronic liver disease

Chronic liver disease is known as the silent killer, showing no obvious symptoms until the disease has progressed to an advanced stage. Therefore, making a proper diagnosis in the early stage of disease progression a clinical challenge. An international team of researchers, affiliated with UNIST, has identified a novel route that regulates the…...

Read more

Molecular profiling could catch lung cancer early and lead to new treatments

Before lung cancer develops, precancerous lesions are found in the airway, but only some of these will actually become lung cancer, while others will disappear or remain benign without becoming harmful. Under the microscope, the lesions look the same, making it difficult to know which lesions to treat. A new…...

Read more

Antibodies to a retina protein to be used as a kidney cancer marker

Tumors can be benign or malignant. Benign tumors can evolve into malignant ones. Around 90 to 93% of all kidney growths turn out to be malignant, and there are currently no effective methods for early diagnostics. The initial stages of kidney cancer have no signs or specific symptoms, so patients are often…...

Read more

What happens if chemotherapy does not work?

Chemotherapy is used by doctors to either as a first-line therapy or in combination with other treatments, such as surgery, to treat cancer. If chemotherapy does not work, a person may need to consider other treatment options. Signs that the cancer is not responding to chemotherapy include the growing or spreading…...

Read more

DNA origami: A precise measuring tool for optimal antibody effectiveness

Using DNA-based designs of precise nanostructures — scientists have been able to demonstrate the most accurate distance between densely packed antigens in order to get the strongest bond to antibodies in the immune system. The study may be of significance to the development of vaccines and immunotherapy used in cancer.…...

Read more